Treatment of Torulopsis glabrata vaginitis: Retrospective review of boric acid therapy

Clinical Infectious Diseases

Volumn 24, Issue 4, 1997, Pages 649-652

  Sobel, Jack D ^a,b   Chaim, Walter ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Henry Ford Health System Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORIC ACID;

BACTERIUM CULTURE; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; TORULOPSIS GLABRATA; VAGINITIS;

EID: 0030895286     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clind/24.4.649     Document Type: Review

References (21)

1. Robertson WH. Mycology of vulvovaginitis. Am J Obstet Gynecol 1988;158:989-91.
2. Center for Disease Control. Nonreported sexually transmissible diseases-United States. MMWR Morb Mortal Wkly Rep 1979;28:61-3.
3. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991;165:1168-76.
4. Fleury FJ. Adult vaginitis. Clin Obstet Gynecol 1981;24:407-38.
5. Odds FC. Candidosis of the genitalia. In: Odds FC, ed. Candida and candidosis. London: Bailliére, 1988:124-35.
6. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann NY Acad Sci 1988;544:547-57.
7. Boquet-Jiménez E, Alvarez San Cristóbal A. Cytologic and microbiologic aspects of vaginal Torulopsis. Acta Cytol (Baltimore) 1978;22:331-4.
8. Goldacre MJ, Milne LJR, Watt B, Loudon N, Vessey MP. Prevalence of yeasts and fungi other than Candida albicans in the vagina of normal young women. Br J Obstet Gynaecol 1981;88:596-600.
9. Lynch ME, Sobel JD. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J Med Vet Mycol 1994;32:267-74.
10. Redondo-Lopez V, Lynch M, Schmitt C, Cook R, Sobel JD. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol 1990;76:651-5.
11. Sobel JD. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol 1994;171:1215-20.
12. Osborne NG, Grubin L, Pratson L. Vaginitis in sexually active women: relationship to nine sexually transmitted organisms. Am J Obstet Gynecol 1982;142:962-7.
13. Oriel JD, Partridge BM, Denny MJ, Coleman JC. Genital yeast infections. Br Med J 1972;4:761-4.
14. Spinillo A, Capuzzo E, Egbe TO, Baltaro F, Nicola S, Piazzi G. Torulopsis glabrata vaginitis. Obstet Gynecol 1995;85:993-8.
15. Sweet RL, Gibbs RS. Infectious vulvovaginitis. In: Sweet RL, Gibbs RS, eds. Infectious diseases of the female genital tract. 2nd ed. Baltimore: Williams & Wilkins, 1990:16-28.
16. Swate TE, Weed JC. Boric acid treatment of vulvovaginal candidiasis. Obstet Gynecol 1974;43:893-5.
17. Van Slyke KK, Michel VF, Rein MF. Treatment of vulvovaginal candidiasis with boric acid powder. Am J Obstet Gynecol 1981;141:145-8.
18. Jovanovic R, Congema E, Nguyen HT. Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis. J Reprod Med 1991;36:593-7.
19. Porter IA, Brodie J. Boric acid preservation of urine samples. Br Med J 1969;2:353-5.
20. Fayinka OA. Boric acid - a useful preservative for urine samples. Afr J Med Sci 1971;2:377-85.
21. Thai L, Hart LL. Boric acid vaginal suppositories. Ann Pharmacother 1993;27:1355-7.